Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?
- PMID: 1737859
- PMCID: PMC442907
- DOI: 10.1172/JCI115640
Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?
Abstract
It has been hypothesized that the tight localization of dystrophin at the muscle membrane is carried out by its cysteine-rich and/or carboxyl domains. We report the results of biochemical and immunocytochemical investigations of dystrophin in muscle from a 1-yr-old patient with a large deletion that removes the distal part of the dystrophin gene, thus spanning the exons coding for the cysteine-rich and the carboxy-terminal domains, and extends beyond the glycerol kinase and congenital adrenal hypoplasia genes. Immunological analysis of muscle dystrophin shows that the deletion results in the production of a truncated, but stable, polypeptide correctly localized at the sarcolemma. These data indicate that neither the cysteine-rich domain, nor the carboxyl domain, are necessary for the appearance of normal dystrophin sarcolemmal localization.
Similar articles
-
Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.J Clin Invest. 1993 Aug;92(2):866-71. doi: 10.1172/JCI116661. J Clin Invest. 1993. PMID: 8349821 Free PMC article.
-
The cysteine-rich and C-terminal domains of dystrophin are not required for normal costameric localization in the mouse.Transgenic Res. 1996 Mar;5(2):123-30. doi: 10.1007/BF01969430. Transgenic Res. 1996. PMID: 8866894
-
Interactions between dystrophin and the sarcolemma membrane.Soc Gen Physiol Ser. 1997;52:19-29. Soc Gen Physiol Ser. 1997. PMID: 9210217
-
Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers.Eur J Cell Biol. 1996 Jan;69(1):1-10. Eur J Cell Biol. 1996. PMID: 8825019 Review.
-
Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.Muscle Nerve. 1994 Jan;17(1):2-15. doi: 10.1002/mus.880170103. Muscle Nerve. 1994. PMID: 8264699 Review.
Cited by
-
Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame.J Med Genet. 1992 Dec;29(12):892-6. doi: 10.1136/jmg.29.12.892. J Med Genet. 1992. PMID: 1479604 Free PMC article.
-
Dystrophin Dp116: A yet to Be Investigated Product of the Duchenne Muscular Dystrophy Gene.Genes (Basel). 2017 Oct 2;8(10):251. doi: 10.3390/genes8100251. Genes (Basel). 2017. PMID: 28974057 Free PMC article. Review.
-
Isolated and contiguous glycerol kinase gene disorders: a review.J Inherit Metab Dis. 2000 Sep;23(6):529-47. doi: 10.1023/a:1005660826652. J Inherit Metab Dis. 2000. PMID: 11032329 Review.
-
The dystrophin superfamily: variability and complexity.J Muscle Res Cell Motil. 1994 Dec;15(6):595-606. doi: 10.1007/BF00121067. J Muscle Res Cell Motil. 1994. PMID: 7706416 Review. No abstract available.
-
An intact cysteine-rich domain is required for dystrophin function.J Clin Invest. 1992 Aug;90(2):666-72. doi: 10.1172/JCI115909. J Clin Invest. 1992. PMID: 1644931 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical